# EDGAR Filing Document

**Accession Number:** 0001838814
**File Stem:** 0000000000-23-003215
**Filing Date:** 2023-3
**Character Count:** 7607
**Document Hash:** 165be79ad4f978613e13a9e30f3713f7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-003215.hdr.sgml**: 20230504

**ACCESSION NUMBER**: 0000000000-23-003215

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230330

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Juniper II Corp.
- **CENTRAL INDEX KEY:** 0001838814
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 14 FAIRMOUNT AVENUE
- **CITY:** CHATHAM
- **STATE:** NJ
- **ZIP:** 07928
- **BUSINESS PHONE:** 9735070359

**MAIL ADDRESS:**
- **STREET 1:** 14 FAIRMOUNT AVENUE
- **CITY:** CHATHAM
- **STATE:** NJ
- **ZIP:** 07928
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-23-080575

## Text-Extract

```

United States securities and exchange commission logo

                              March 30, 2023

       Murray Grainger
       Chief Executive Officer
       Juniper II Corp.
       3790 El Camino Real #818
       Palo Alto, CA 94306

                                                        Re: Juniper II Corp.
                                                            Preliminary Proxy
Statement filed on Schedule 14A
                                                            Filed March 27,
2023
                                                            File No. 001-41014

       Dear Murray Grainger:

             We have reviewed your filing and have the following comment. In
our comment, we
       may ask you to provide us with information so we may better understand
your disclosure.

              Please respond to this comment within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comment applies to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to this comment, we may have additional comments.

       Preliminary Proxy Statement filed on Schedule 14A

       General

   1.                                                   With a view toward
disclosure, please tell us whether your sponsor is, is controlled by, has
                                                        any members who are, or
has substantial ties with, a non-U.S. person. Also revise your
                                                        filing to include risk
factor disclosure that addresses how this fact could impact your
                                                        ability to complete
your initial business combination. For instance, discuss the risk to
                                                        investors that you may
not be able to complete an initial business combination with a
                                                        target company should
the transaction be subject to review by a U.S. government entity,
                                                        such as the Committee
on Foreign Investment in the United States (CFIUS), or ultimately
                                                        prohibited. Disclose
that as a result, the pool of potential targets with which you could
                                                        complete an initial
business combination may be limited. Further, disclose that the time
                                                        necessary for
government review of the transaction or a decision to prohibit the
                                                        transaction could
prevent you from completing an initial business combination and require
                                                        you to liquidate.
Disclose the consequences of liquidation to investors, such as the losses
                                                        of the investment
opportunity in a target company, any price appreciation in the combined
 Murray Grainger
Juniper II Corp.
March 30, 2023
Page 2
      company, and the warrants, which would expire worthless.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Please contact Joseph Ambrogi at 202-551-4821 or David Link at
202-551-3356 with any
other questions.

                                                          Sincerely,
FirstName LastNameMurray Grainger
                                                          Division of
Corporation Finance
Comapany NameJuniper II Corp.
                                                          Office of Real Estate
& Construction
March 30, 2023 Page 2
cc:       Julian Seiguer, Esq.
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

March 30, 2023

Murray Grainger  
Chief Executive Officer  
Juniper II Corp.  
3790 El Camino Real #818  
Palo Alto, CA 94306

**Re: Juniper II Corp.**

**Preliminary Proxy Statement filed on Schedule 14A**

**Filed March 27, 2023**

**File No. 001-41014**

Dear Murray Grainger:

We have reviewed your filing and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response.

After reviewing your response to this comment, we may have additional comments.

# Preliminary Proxy Statement filed on Schedule 14A

# General

1. With a view toward disclosure, please tell us whether your sponsor is, is controlled by, has any members who are, or has substantial ties with, a non-U.S. person. Also revise your filing to include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined

Murray Grainger
Juniper II Corp.
March 30, 2023
Page 2

company, and the warrants, which would expire worthless.

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Joseph Ambrogi at 202-551-4821 or David Link at 202-551-3356 with any other questions.

Sincerely,

Division of Corporation Finance
Office of Real Estate & Construction

cc: Julian Seiguer, Esq.